Disciplined Growth Acquisition
DGAC · NYSE
About DGAC
- Employees
- 0
- Headquarters
- Garden City, New York
- Listed
- May 27, 2026
- Sector
- N/A
- Industry
- N/A
DGAC key statistics
- Market cap
- 221.08M
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 21.47K
- Volume
- 4.11K
- Open price
- $10.02
- High today
- $10.02
- Low today
- $10.02
- 52 Week high
- $10.02
- 52 Week low
- $9.85
Disciplined Growth Acquisition (DGAC) at a glance
Disciplined Growth Acquisition (DGAC) last traded at $10.02, with a market cap of 221.08M and a price-to-earnings ratio of 0.00.
Volume so far is 4.11K shares, below the average of 21.47K shares a day.
Over the past year Disciplined Growth Acquisition has ranged from $9.85 to $10.02, and now sits 100% of the way up that range.
Most active stocks
Highest trading volume today
- RDARRaadr$0.0002+0.00%
- DVLTDatavault AI$0.0879+31.19%
- RCTRedCloud Holdings$0.0617−5.95%
- TIPSTianrong Internet Products & Services$0.0014+27.27%
- GTVHGolden Triangle Ventures$0.0002+0.00%
- AITXArtificial Intelligence Technology Solutions$0.0005−43.75%
- CDTCDT Equity$0.083+3.75%
- EARIEntertainment Arts Research$0.0002+0.00%
- NBNDNetBrands$0.0006−14.29%
- NVDGraniteShares ETF Trust$4.01+2.04%
- STLAStellantis N.V$4.68+13.04%
- NTRRNeutra$0.0002+0.00%
Newly listed
Companies that went public in the past six weeks
- SCQCUSPACCircle Acquisition$9.97−0.05%
- LYCALycia Therapeutics$25.05−4.06%
- DAVIDAVION HEALTHCARE$3.29+9.67%
- TCXBTCGX Acquisition Corp. II$10.27−0.10%
- CTYCITY THERAPEUTICS$21.65+3.79%
- IAMIambic Therapeutics$14.78+5.57%
- AMROAmaero$5.86−2.98%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.23−0.49%
- TRXBTRex Bio$14.43+4.64%
- RTSNRetension Pharmaceuticals$13.09−3.18%
- PAXGUPine Tree Acquisition$10.02+0.20%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.